Micro RNAs Promoting Growth and Metastasis in Preclinical In Vivo Models of Subcutaneous Melanoma
CANCER GENOMICS & PROTEOMICS
Authors: Weidle, Ulrich H.; Auslander, Simon; Brinkmann, Ulrich
Abstract
During the last years a considerable therapeutic progress in melanoma patients with the RAF V600E mutation via RAF/MEK pathway inhibition and immunotherapeutic modalities has been witnessed. However, the majority of patients relapse after therapy. Therefore, a deeper understanding of the pathways driving oncogenicity and metastasis of melanoma is of paramount importance. In this review, we summarize microRNAs modulating tumor growth, metastasis, or both, in preclinical melanoma-related in vivo models and possible clinical impact in melanoma patients as modalities and targets for treatment of melanoma. We have identified miR-199a (ApoE, DNAJ4), miR-7-5p (RelA), miR-98a ( IL6), miR-219-5p (BCL2) and miR-365 (NRP1) as possible targets to be scrutinized in further target validation studies.
Retinal functioning and reward processing in schizophrenia
SCHIZOPHRENIA RESEARCH
Authors: Demmin, Docia L.; Mote, Jasmine; Beaudette, Danielle M.; Thompson, Judy L.; Silverstein, Steven M.
Abstract
Retinal responses to light, as measured by electroretinography (ERG), have been shown to be reduced in schizo- phrenia. Data from a prior ERG study in healthy humans indicated that activity of a retinal cell type affected in schizophrenia can be modi fied by the presence of a food reward. Therefore, we aimed to determine whether ERG amplitudes would be sensitive to the well -documented reward processing impairment in schizophrenia. Flash ERG data from 15 clinically stable people with schizophrenia or schizoaffective disorder and 15 healthy con- trols were collected under three conditions: baseline, anticipation of a food reward, and immediately after con- suming the food reward. At the group level, data indicated that controls' ERG responses varied as a function of salience of the food reward (baseline vs. anticipation vs. consumption) whereas patients' ERG responses did not vary signi ficantly across conditions. Correlations between ERG amplitudes and scores on measures of hedonic capacity (including motivation and pleasure negative symptom ratings for patients) indicated consistent rela- tionships. These data suggest that flash ERG amplitudes may be a sensitive indicator of the integrity of reward processing mechanisms. However, several differences in the direction of findings between this and a prior study in controls point to the need for further investigation of the contributions of a number of key variables to the observed effects.